Glioblastoma: Molecular and Clinical Trials

Edited by Dr. Linda M. Liau, this issue of Neurosurgery Clinics delves into the complex and multifaceted topic of Glioblastoma, focusing on molecular and clinical trials. This comprehensive publication is one of four selected annually by the series consulting editors, Drs. Russell R. Lonser and Daniel K. Resnick.

Key Topics Covered

This issue covers a wide range of topics, including but not limited to:

• Pathology & Molecular Markers
• Cellular States & Genetic Diversity in Glioblastoma
• Mismatch Repair in Glioblastoma Resistance
• Genetic Susceptibility in Brain Cancer
• Pediatric Gliomas: Molecular Landscape & Emerging Targets
• Molecularly Targeted Clinical Trials
• Novel Radiation Sensitizers
• Immunotherapy Checkpoint Inhibitors
• Brain Tumor Vaccines
• CAR T Cells
• Oncolytic Virotherapy
• Targeting Cancer Stem Cells
• Therapeutic Delivery to CNS
• Theranostics: Dual Modality PET Tracers
• Neuroimaging & Novel Response Assessments

Publication Details

Published by Elsevier, this hardcover edition was released on May 3, 2021. It comprises 240 pages and is available in English. The ISBN-10 is 0323813054, and the ISBN-13 is 978-0323813051.

This publication is an essential resource for medical professionals, researchers, and students seeking comprehensive insights into the latest advancements in Glioblastoma research and treatment. It provides a detailed exploration of the molecular and clinical aspects of this complex disease, offering valuable information for those working in the field of neurosurgery and oncology.